Shaemus gleason

RVP Clarity Pharmaceuticals

Seminars

Wednesday 12th November 2025
Translational & Clinical Development Track
Tuesday 11th November 2025
Strategies to Mitigate Isotope Supply Challenges for Actinium to Ensure Consistent Supply
11:00 am
  • Navigating reliance on decommissioned nuclear materials and government-controlled isotope stock
  • Exploring scalable actinium and terbium generation methods
  • How companies are hedging risk by contracting with multiple suppliers and monitoring delivery readiness
Wednesday 12th November 2025
Creating an Ecosystem for Widespread TRP Adoption Across Regions
12:00 pm
  •  Showcasing successful national TRP rollouts (e.g., Belgium) to guide broader uptake
  • Understanding the role of government buy-in, reimbursement pathways, and commissioning
  • Scaling physical infrastructure and staffing to meet growing therapeutic demand
Shaemus Gleason, Executive Vice President, Clarity Pharmaceuticals